Ivabradine in Catecholamine-Induced Tachycardia in a Patient with Paraganglioma

N Engl J Med. 2019 Mar 28;380(13):1284-1286. doi: 10.1056/NEJMc1817267.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Cardiovascular Agents / therapeutic use*
  • Catecholamines / physiology*
  • Humans
  • Ivabradine / therapeutic use*
  • Male
  • Middle Aged
  • Norepinephrine / blood
  • Octreotide / analogs & derivatives
  • Octreotide / pharmacology
  • Octreotide / therapeutic use
  • Organometallic Compounds / pharmacology
  • Organometallic Compounds / therapeutic use
  • Paraganglioma / complications*
  • Paraganglioma / radiotherapy
  • Tachycardia / drug therapy*
  • Tachycardia / etiology

Substances

  • Cardiovascular Agents
  • Catecholamines
  • Organometallic Compounds
  • Ivabradine
  • lutetium Lu 177 dotatate
  • Octreotide
  • Norepinephrine